You're reading the free version. Trader adds the live tape and alerts.
Start tracking
AKTX Award Disclosure
Farag Kameel D. · SEC Form 4 · Filed Jun 25, 2026
Award
Calculated transaction value
$13K
Farag Kameel D. Interim CFO
AKTX
Transaction date
Jun 24, 2026
Public filing date
Jun 25, 2026
Filing lag
Filed 1 day later
AKTX daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- American Depositary Shares representing Ordinary Shares
- Quantity / price
- 1,570 shares @ $8.28
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001493152-26-030210
Filing cohort
Transactions in this filing
Showing 7 of 7
Trades
7
Issuers
1
Estimated value
$105.01K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Akari Therapeutics Plc AKTX | Award | Jun 24, 2026 | $12.5K |
| Akari Therapeutics Plc AKTX | Award | Jun 24, 2026 | $13K |
| Akari Therapeutics Plc AKTX Current | Award | Jun 24, 2026 | $13K |
| Akari Therapeutics Plc AKTX | Award | Jun 24, 2026 | $13K |
| Akari Therapeutics Plc AKTX | Award | Jun 24, 2026 | $13K |
| Akari Therapeutics Plc AKTX | Award | Jun 24, 2026 | $27.5K |
| Akari Therapeutics Plc AKTX | Award | Jun 24, 2026 | $13K |